Eric Schmidt, analyst at SG Cowen, predicts Ciphergen will eke out a slight profit in 2004.

FORBES: When The Bio Chips Are Down

Instead of looking at genes, Ciphergen's ProteinChip provides a way of looking at which proteins are present in the cell.

FORBES: Magazine Article

Some of Ho's colleagues doubt that he has the right protein, but if he does, that could give Ciphergen's prospects a boost by providing proof that its technology really does work.

FORBES: Magazine Article

Ciphergen is off 62% from its 52-week high.

FORBES: Magazine Article

Ciphergen's approach may already be bearing fruit.

FORBES: When The Bio Chips Are Down